Growth hormone secretagogue (ghrelin receptor agonist)
Ipamorelin
Growth hormone secretagogue (ghrelin receptor agonist). Supplied for laboratory research use only.
- Ghrelin agonist; reached Phase 2 for post-surgical ileus
- Never approved; FDA Category 2 restricted since 2023
- Not recommended for compounding list, Oct 2024 PCAC vote
- Supplied for laboratory research use only. Not for human or veterinary use.
90-Day Money-Back Guarantee
Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.
Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.
What it is
Development status
Ipamorelin is an investigational compound and is not approved by the FDA for any indication. It is in Phase 2 clinical trials.
Never received FDA approval for any indication; reached Phase 2 for post-surgical ileus and was not advanced to Phase 3. In 2023 the FDA placed ipamorelin on its Category 2 bulk drug substances list, which restricts the compounding pathway in the US.
Shipping & returns
The specifics
The details, if you want them.
Development
Where it is up to.
Reached Phase 2 human trials for one indication, post-surgical ileus, but was not advanced to Phase 3.
Questions
The questions people actually ask.
What is ipamorelin?
Is ipamorelin approved by the FDA?
What does "Research Use Only" mean?
How is ipamorelin supplied?
What is your refund policy?
